Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Why FDA's approval of genetic therapy is such a big deal

Duration: 01:20s - Published: < > Embed
News video: Why FDA's approval of genetic therapy is such a big dealOn Thursday, an FDA advisory panel gave the green light for a therapy that could improve the vision of people who have a rare genetic disorder called Leber's congenital amaurosis (LCA). CBS News medical contributor Dr. Tara Narula weighs in.

0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

The First Gene Therapy That Fixes Hereditary Blindness May Finally Get FDA Approval

A gene therapy treatment called Luxturna has already improved the eyesight of people suffering from a...
Futurism - Science

FDA Panel Recommends Approval Of Gene Therapy To Treat Form Of Blindness

FDA Panel Recommends Approval Of Gene Therapy To Treat Form Of BlindnessA potentially groundbreaking treatment for a rare form of blindness moved one step closer to U.S....
WorldNews - Front PageAlso reported by •SeattlePI.comUSATODAY.combizjournalsFuturism


Spark Therapeutics surge premarket after getting FDA committee endorses its blindness treatment

Spark Therapeutics Inc. (NASDAQ:ONCE) shares surged in premarket trade after a U.S. Food and Drugs...
Proactive Investors - Business

Exelixis shares soar on news FDA grants priority review to its kidney cancer drug

Biotech Exelixis Inc. (NASDAQ:EXEL) saw its shares surge in premarket trade on Monday after the U.S....
Proactive Investors - Business


You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+